PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33655698-8	2021	Histone-lysine N-methyltransferase 2 (KMT2) family members (KMT2A, KMT2C, and KMT2D) were frequently mutated in NSCLC tumors, and these mutations were associated with higher TMB and PD-L1 expression, as well as higher PD-L1+/TMB-H proportions.	tyrosyl-lysine	8-14	lysine methyltransferase 2D	Homo sapiens	78-83	
32024448-8	2020	Seven patients also had somatic mutations in APC, and seven patients harbored somatic mutations in KMT2D, which encodes a lysine methyl transferase.	tyrosyl-lysine	122-135	lysine methyltransferase 2D	Homo sapiens	99-104	
31813957-3	2020	The major cause of Kabuki syndrome are mutations in KMT2D, a gene encoding a histone H3 lysine 4 (H3K4) methyltransferase belonging to the group of chromatin modifiers.	tyrosyl-lysine	88-96	lysine methyltransferase 2D	Homo sapiens	52-57	
31654559-1	2020	Kabuki syndrome (KS) is a disorder of epigenetic dysregulation due to heterozygous mutations in KMT2D or KDM6A, genes encoding a lysine-specific methyltransferase or demethylase, respectively.	tyrosyl-lysine	129-135	lysine methyltransferase 2D	Homo sapiens	96-101	
31924266-1	2020	The type 2 lysine methyltransferases KMT2C and KMT2D are large, enzymatically active scaffold proteins that form the core of nuclear regulatory structures known as KMT2C/D COMPASS complexes (complex of proteins associating with Set1).	tyrosyl-lysine	11-17	lysine methyltransferase 2D	Homo sapiens	47-52